RO increased the levels of ERβ in both hormone-dependent LNCaP and castration-resistant PC-3 prostate cancer cells, demonstrating an anti-proliferative effect similar to that observed in breast cancer cells. The gene discussed is ESR2; the disease is breast carcinoma.